GIA
CVS icon

Guyasuta Investment Advisors’s CVS Health CVS Stock Holding History

Guyasuta Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$348K Sell
3,364
-89
-3% -$7.94K 0.02% 216
2026
Q1 		$248K Buy
3,453
+33
+1% +$2.54K 0.01% 250
2025
Q4 		$271K Buy
3,420
+11
+0.3% +$867 0.02% 230
2025
Q3 		$257K Sell
3,409
-1,304
-28% -$89.4K 0.01% 232
2025
Q2 		$325K Buy
4,713
+1,330
+39% +$87.2K 0.02% 205
2025
Q1 		$229K Buy
+3,383
New +$202K 0.02% 229
2024
Q4 		– Sell
-3,406
Closed -$214K – 268
2024
Q3 		$214K Buy
3,406
+515
+18% +$30K 0.01% 259
2024
Q2 		$228K Hold
2,891
– – 0.02% 232
2024
Q1 		$228K Hold
2,891
– – 0.02% 233
2023
Q4 		$228K Sell
2,891
-1,475
-34% -$105K 0.02% 233
2023
Q3 		$305K Sell
4,366
-3,230
-43% -$229K 0.02% 183
2023
Q2 		$525K Buy
7,596
+750
+11% +$53.4K 0.04% 151
2023
Q1 		$509K Buy
6,846
+1,989
+41% +$167K 0.04% 151
2022
Q4 		$453K Sell
4,857
-157
-3% -$15.1K 0.04% 152
2022
Q3 		$478K Buy
5,014
+326
+7% +$32.3K 0.04% 143
2022
Q2 		$434K Sell
4,688
-1,750
-27% -$171K 0.03% 183
2022
Q1 		$652K Sell
6,438
-57
-0.9% -$5.99K 0.04% 163
2021
Q4 		$670K Hold
6,495
– – 0.04% 165
2021
Q3 		$551K Buy
6,495
+2,250
+53% +$188K 0.04% 174
2021
Q2 		$354K Hold
4,245
– – 0.03% 208
2021
Q1 		$319K Sell
4,245
-7,825
-65% -$570K 0.02% 206
2020
Q4 		$824K Buy
12,070
+80
+0.7% +$5.2K 0.07% 129
2020
Q3 		$700K Buy
11,990
+3,402
+40% +$212K 0.07% 125
2020
Q2 		$558K Buy
8,588
+4,650
+118% +$293K 0.06% 134
2020
Q1 		$234K Sell
3,938
-2,250
-36% -$150K 0.03% 170
2019
Q4 		$460K Hold
6,188
– – 0.04% 151
2019
Q3 		$390K Sell
6,188
-3,500
-36% -$207K 0.04% 154
2019
Q2 		$528K Buy
9,688
+3,145
+48% +$169K 0.05% 142
2019
Q1 		$353K Buy
+6,543
New +$404K 0.04% 162
2018
Q4 		– Sell
-3,043
Closed -$240K – 194
2018
Q3 		$240K Sell
3,043
-500
-14% -$35.7K 0.03% 196
2018
Q2 		$228K Buy
3,543
+72
+2% +$4.75K 0.03% 196
2018
Q1 		$216K Buy
+3,471
New +$249K 0.03% 204
2017
Q2 		– Sell
-10,071
Closed -$791K – 212
2017
Q1 		$791K Sell
10,071
-8,785
-47% -$701K 0.1% 115
2016
Q4 		$1.49M Sell
18,856
-2,205
-10% -$178K 0.19% 63
2016
Q3 		$1.87M Buy
21,061
+1,360
+7% +$128K 0.24% 57
2016
Q2 		$1.89M Sell
19,701
-555
-3% -$55.3K 0.25% 52
2016
Q1 		$2.1M Buy
20,256
+4,500
+29% +$438K 0.29% 51
2015
Q4 		$1.54M Buy
15,756
+5
+0% +$490 0.22% 59
2015
Q3 		$1.52M Buy
15,751
+4,680
+42% +$492K 0.22% 56
2015
Q2 		$1.16M Hold
11,071
– – 0.15% 79
2015
Q1 		$1.14M Sell
11,071
-870
-7% -$88K 0.15% 77
2014
Q4 		$1.15M Buy
11,941
+1,658
+16% +$146K 0.15% 78
2014
Q3 		$818K Sell
10,283
-500
-5% -$39.4K 0.11% 104
2014
Q2 		$812K Sell
10,783
-945
-8% -$71.4K 0.11% 114
2014
Q1 		$877K Hold
11,728
– – 0.13% 98
2013
Q4 		$839K Hold
11,728
– – 0.12% 104
2013
Q3 		$665K Buy
11,728
+6,000
+105% +$358K 0.11% 114
2013
Q2 		$327K Buy
+5,728
New +$332K 0.05% 146

Other funds holding CVS

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Guyasuta Investment Advisors's CVS Position: Q2 2026 in Review

Guyasuta Investment Advisors reduced its CVS Health (CVS) stake by 2.6% in Q2 2026, selling an estimated $7.94K and leaving 3,364 shares worth $348K. The position accounts for 0.02% of the portfolio, ranked #216.

Guyasuta Investment Advisors first reported a position in CVS in Q2 2013 and has held it in 48 quarters since. The position peaked at $2.1M in Q1 2016. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Guyasuta Investment Advisors held 3,364 shares of CVS Health worth $348K as of Q2 2026.
  • Guyasuta Investment Advisors sold 89 CVS Health shares in Q2 2026, an estimated $7.94K.
  • CVS Health made up 0.02% of Guyasuta Investment Advisors's portfolio in Q2 2026, its #216 holding.
  • Guyasuta Investment Advisors first reported a position in CVS Health in Q2 2013 and has held it in 48 quarters since.
  • Guyasuta Investment Advisors's CVS Health position peaked at $2.1M in Q1 2016.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Guyasuta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.